Delivering Breakthrough Analytics for Drug Development

At Clinical SCORE, we blend traditional market research with statistical evidence to give you granular insights into issues impeding progress across your drug development progression using our proprietary processes.

For Clinical Markets, our Engage product is the ultimate tool for effective study management. With the launch of CRO Report Card, we bring comprehensive trial access to the C-Suite through our effective partnership with Tableau to bring you real-time dashboard access to enhance CRO and Sponsor relationships. You can read more about our work in Clinical in Applied Clinical Trials Online and Clinical Leader.

Our Commercial Market offerings, Clinical Trial Insights (CTI) and CTI Plus, bring the voices of patients with a hands-on experience to your post-clinical and commercial marketing efforts. This unique approach is so effective, select major sponsor organisations already have instituted it as a brand standard. Some of our work within the Commercial segment is featured on Clinical Leader. Our Managing Director Ross Weaver brings his over 30-year history within Pharma to drive effective commercialization of your products.

We are at the forefront in Medical Affairs with our Partner of Choice product. This analytic tool provides the evidence that heads of Medical Affairs need to differentiate their MSLs and KOLs value proposition across therapeutic areas, geographies, or even needs segments.
We also offer our proprietary Medical Affairs Perspectives Series, available by monthly newsletter subscription or published on Pharmaceutical Executive. Our in-house Medical Affairs research specialist, Gary Kaplan, is widely regarded as a breakthrough voice in providing evidentiary support for Medical Affairs programs through current research and analysis.

Contact us now to learn more.